Vericel Corp

VCEL

Market cap $1.8B

35.37 USD

+0.23

0.65%

At close Updated Apr 15, 4:00 PM EDT

Pre-market

After hours

35.37

0.00

1 day

0.65%

5 days

4.74%

1 month

9.54%

3 months

-8.3%

6 months

5.3%

Year to date

-0.67%

1 year

-15.83%

5 years

-39%

10 years

934.21%

About: Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 398

Healthcare Biotechnology